a.halonen
Submits third-party assay reports on material purchased directly. Based in Rosario.
Section 1
Contribution
Purchases material, pays for assays, and submits the resulting reports to the index.
Records submitted
10
n=10
Annotations
0
n=0
Median purity submitted
99.30%
n=10
Suppliers covered
9
n=10
Section 2
Records submitted
A submitter chose to buy this material and to pay for this assay. That choice is the selection mechanism behind the whole index and it is not random.
| Report | Compound | Supplier | Lot | Lab | Quarter | Purity % | Water % | Recovery % | Provenance | Flags | Result |
|---|---|---|---|---|---|---|---|---|---|---|---|
| AX-2026-042090 | MOTS-c | HYB | HYB-2606-D7858 | Janoshik | 2026-Q3 | 99.57 | 2.36 | — | Buyer-sourced | 1 | FAIL |
| AX-2026-042240 | Humanin (HNG) | TFC | TFC-2608-S9940 | Janoshik | 2026-Q3 | 98.50 | 1.95 | — | Buyer-sourced | 0 | PASS |
| AX-2026-042224 | SS-31 (Elamipretide) | TFC | TFC-2607-R9099 | VendorInvestigate | 2026-Q3 | 99.79 | 4.86 | — | Buyer-sourced | 0 | PASS |
| AX-2026-041868 | CJC-1295 with DAC | SinoPep | SNP-2607-C3886 | Janoshik | 2026-Q3 | 99.09 | 5.90 | 91.8 | Buyer-sourced | 0 | PASS |
| AX-2026-042483 | N-Acetyl Semax Amide | Homopeptide | HOMO-2603-C5267 | Janoshik | 2026-Q2 | 99.10 | 8.34 | — | Buyer-sourced | 0 | PASS |
| AX-2026-041728 | TB-500 | TFS | TFS-{CAT}-9979 | Janoshik | 2026-Q1 | 99.70 | 3.97 | 94.8 | Buyer-sourced | 0 | PASS |
| AX-2025-019996 | IGF-1 LR3 | SWB | SWB-2510-U7690 | Janoshik | 2025-Q4 | 98.21 | 6.20 | — | Buyer-sourced | 0 | PASS |
| AX-2025-018494 | MOTS-c | WWB | WWB-2505-G2801 | Janoshik | 2025-Q3 | 99.80 | 3.08 | — | Buyer-sourced | 0 | PASS |
| AX-2025-020874 | BPC-157 | WXT | WXT-2506-M1881 | Janoshik | 2025-Q3 | 99.50 | 3.18 | 105.2 | Supplier-supplied | 0 | PASS |
| AX-2025-020356 | Enclomiphene citrate | MKM | MKM-2408-L3879 | Janoshik | 2025-Q1 | 98.98 | 4.27 | — | Supplier-supplied | 0 | FAIL |